130 related articles for article (PubMed ID: 6620051)
21. Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis.
Marchand V; Baker SS; Stark TJ; Baker RD
J Pediatr Gastroenterol Nutr; 2000 Sep; 31(3):264-9. PubMed ID: 10997370
[TBL] [Abstract][Full Text] [Related]
22. Dietary supplementation with pressurized whey in patients with cystic fibrosis.
Lands LC; Iskandar M; Beaudoin N; Meehan B; Dauletbaev N; Berthiuame Y
J Med Food; 2010 Feb; 13(1):77-82. PubMed ID: 20136439
[TBL] [Abstract][Full Text] [Related]
23. Nutritional rehabilitation increases resting energy expenditure without affecting protein turnover in patients with cystic fibrosis.
Vaisman N; Clarke R; Pencharz PB
J Pediatr Gastroenterol Nutr; 1991 Nov; 13(4):383-90. PubMed ID: 1779312
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone-induced changes in myofibrillar protein breakdown in hypopituitary children.
Ballard FJ; Burgoyne JL; Tomas FM; Penfold JL
Clin Sci (Lond); 1983 Mar; 64(3):315-20. PubMed ID: 6822063
[TBL] [Abstract][Full Text] [Related]
25. Caloric intake and eating behavior in infants and toddlers with cystic fibrosis.
Powers SW; Patton SR; Byars KC; Mitchell MJ; Jelalian E; Mulvihill MM; Hovell MF; Stark LJ
Pediatrics; 2002 May; 109(5):E75-5. PubMed ID: 11986481
[TBL] [Abstract][Full Text] [Related]
26. Chronic undernutrition/growth retardation in cystic fibrosis.
Soutter VL; Kristidis P; Gruca MA; Gaskin KJ
Clin Gastroenterol; 1986 Jan; 15(1):137-55. PubMed ID: 3082541
[TBL] [Abstract][Full Text] [Related]
27. Onset and evolution of stunting in infants and children. Examples from the Human Nutrition Collaborative Research Support Program. Kenya and Egypt studies.
Neumann CG; Harrison GG
Eur J Clin Nutr; 1994 Feb; 48 Suppl 1():S90-102. PubMed ID: 8005095
[TBL] [Abstract][Full Text] [Related]
28. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of the lean body and/or muscle mass in children receiving artificial nutrition. Comparative value of anthropometric data and the urinary excretion of creatinine and 3-methylhistidine].
Ghisolfi J; Landetcheverry O; Olives JP; Thouvenot JP; Nguyen VB; Vaux J
Arch Fr Pediatr; 1984; 41(6):385-9. PubMed ID: 6435589
[TBL] [Abstract][Full Text] [Related]
30. Growth and body composition in infants with bronchopulmonary dysplasia up to 3 months corrected age: a randomized trial of a high-energy nutrient-enriched formula fed after hospital discharge.
Brunton JA; Saigal S; Atkinson SA
J Pediatr; 1998 Sep; 133(3):340-5. PubMed ID: 9738713
[TBL] [Abstract][Full Text] [Related]
31. Urinary excretion of 3-methylhistidine: an assessment of muscle protein catabolism in adult normal subjects and during malnutrition, sepsis, and skeletal trauma.
Long CL; Birkhahn RH; Geiger JW; Betts JE; Schiller WR; Blakemore WS
Metabolism; 1981 Aug; 30(8):765-76. PubMed ID: 6790901
[TBL] [Abstract][Full Text] [Related]
32. Dietary intake in children and adolescents with cystic fibrosis.
Woestenenk JW; Castelijns SJ; van der Ent CK; Houwen RH
Clin Nutr; 2014 Jun; 33(3):528-32. PubMed ID: 23920501
[TBL] [Abstract][Full Text] [Related]
33. Body composition of children with myelomeningocele, determined by 40K, urinary creatinine and anthropometric measures.
Grogan CB; Ekvall SM
J Am Coll Nutr; 1999 Aug; 18(4):316-23. PubMed ID: 12038474
[TBL] [Abstract][Full Text] [Related]
34. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
[TBL] [Abstract][Full Text] [Related]
35. Muscle protein degradation in severely malnourished patients with chronic obstructive pulmonary disease subject to short-term total parenteral nutrition.
Aguilaniu B; Goldstein-Shapses S; Pajon A; Levy P; Sarrot F; Leverve X; Page E; Askanazi J
JPEN J Parenter Enteral Nutr; 1992; 16(3):248-54. PubMed ID: 1501355
[TBL] [Abstract][Full Text] [Related]
36. Myofibrillar protein degradation in the chicken. 3-Methylhistidine release in vivo and in vitro in normal and genetically muscular-dystrophic chickens.
Hillgartner FB; Williams AS; Flanders JA; Morin D; Hansen RJ
Biochem J; 1981 May; 196(2):591-601. PubMed ID: 7316997
[TBL] [Abstract][Full Text] [Related]
37. Interaction of thyroid status and diet on muscle protein breakdown in the rat, as measured by N tau-methylhistidine excretion.
Burini R; Santidrian S; Moreyra M; Brown P; Munro HN; Young VR
Metabolism; 1981 Jul; 30(7):679-87. PubMed ID: 7242372
[TBL] [Abstract][Full Text] [Related]
38. Protein degradation in muscle: response to feeding and fasting in growing rats.
Wassner SJ; Orloff S; Holliday MA
Am J Physiol; 1977 Aug; 233(2):E119-23. PubMed ID: 888948
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the macronutrient intake of healthy controls and children with cystic fibrosis on low fat or nonrestricted fat diets.
Daniels L; Davidson GP; Martin AJ
J Pediatr Gastroenterol Nutr; 1987; 6(3):381-6. PubMed ID: 3430247
[TBL] [Abstract][Full Text] [Related]
40. Myofibrillar protein degradation in premature infants with respiratory distress as assessed by 3-methylhistidine and creatinine excretions.
Lunyong VE; Friedman Z
Am J Clin Nutr; 1982 Sep; 36(3):485-91. PubMed ID: 7113954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
